Pulmonary complications in leptospirosis, though common, are often unrecognized in a non-endemic area. We report here a patient with leptospirosis and severe pulmonary involvement who was treated with meropenem (1 g every 8 hours), moxifloxacin (400 mg once daily), and high doses of corticosteroids. Systemic steroids were continued for 3 months because of persistent pulmonary lesions.
|Number of pages||5|
|Journal||Sultan Qaboos University Medical Journal|
|Publication status||Published - May 2013|
- Case report
- Human ARDS
ASJC Scopus subject areas